SMMT
#867
Summit Therapeutics Inc. - Common Stock
13.7 1 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.33%
Variación mensual
+8.72%
Variación en los últimos 6 meses
-15.16%
Cambio anual
-30.97%
Cierres anteriores
14.3 3
Open
13.6 8
Mínimo
13.6 5
Máximo
13.7 8
Volumen
2 096
Financials
- Market Capitalization 10.94 B
- Employee 265
- Founded 2003
- CEO Robert DugganMaky Zanganeh
- Website www.smmttx.com
- Headquarter Florida, United States
- FIGI BBG00X3GQL76
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-12.15
Relación precio/flujo de caja
-21.44 K
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 826 |  HALO Halozyme Therapeutics, Inc. - Common Stock | 105.35 USD | -1.47% | -2.61% | +26.81% | +57.71% | 11.96 B USD | ||
| 854 |  TECH Bio-Techne Corp - Common Stock | 72.35 USD | -0.17% | +0.04% | +0.31% | +33.61% | 11.35 B USD | ||
| 885 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 199.00 USD | -3.52% | -4.22% | -15.65% | +52.84% | 10.42 B USD | ||
| 893 |  KRYS Krystal Biotech, Inc. - Common Stock | 351.28 USD | -1.73% | +1.36% | -2.94% | +87.72% | 10.40 B USD |